1-8 of 8
Artur Mitterer
Close
Sort by
Journal Articles

Development of BAX 826, a Polysialylated Full-Length rFVIII with Significantly Improved PK Properties

Peter L. Turecek, PhD, Juergen Siekmann, PhD, Artur Mitterer, PhD, Michael Graninger, PhD, Gerald Schrenk, PhD, Peter Matthiessen, PhD, Hanspeter Rottensteiner, PhD, Werner Hoellriegl, DVM, Marietta Putz, MS, Hans Peter Schwarz, MD, Friedrich Scheiflinger, PhD
Journal: Blood
Blood (2015) 126 (23): 3536.
https://doi.org/10.1182/blood.V126.23.3536.3536
Published: 2015
Journal Articles

Structural Characterization of Baxter's Recombinant Human ADAMTS13 Drug Candidate.

Alexandra Foettinger-Vacha, Martin Kaliwoda, PhD, Peter Matthiessen, PhD, Meinhard Hasslacher, PhD, Hanspeter Rottensteiner, PhD, Peter L Turecek, PhD, Artur Mitterer, PhD, Friedrich Scheiflinger, PhD
Journal: Blood
Blood (2012) 120 (21): 2236.
https://doi.org/10.1182/blood.V120.21.2236.2236
Published: 2012
Journal Articles

Structural Characterization of BAX 855, a PEGylated Recombinant FVIII

Martin Kaliwoda, PhD, Michael Graninger, PhD, Peter Matthiessen, PhD, Gerald Schrenk, PhD, Peter L Turecek, PhD, Artur Mitterer, PhD, Hartmut J. Ehrlich, MD, Friedrich Scheiflinger, PhD
Journal: Blood
Blood (2011) 118 (21): 4356.
https://doi.org/10.1182/blood.V118.21.4356.4356
Published: 2011
Journal Articles

Development of a Large Scale Production Process for BAX 855, a PEGylated rFVIII Product with Prolonged Half-Life

Jürgen Siekmann, PhD, Purtscher Martin, PhD, Oliver Zöchling, Robert Kellerer, Hanspeter Rottensteiner, PhD, Artur Mitterer, PhD, Marry Bossard, PhD, Gayle Phillips, Hartmut J. Ehrlich, MD, Friedrich Scheiflinger, PhD, Peter L Turecek, PhD
Journal: Blood
Blood (2011) 118 (21): 4362.
https://doi.org/10.1182/blood.V118.21.4362.4362
Published: 2011
Journal Articles

Functional Characterization of a Recombinant FVIIa Drug Candidate

Peter L Turecek, PhD, Katalin Varadi, PhD, Susanne Vejda, PhD, Ernst Boehm, PhD, Hanspeter Rottensteiner, PhD, Hans Peter Schwarz, PhD, Artur Mitterer, PhD, Wolfgang Mundt, PhD, Hartmut J. Ehrlich, MD, Friedrich Scheiflinger, PhD
Journal: Blood
Blood (2010) 116 (21): 4653.
https://doi.org/10.1182/blood.V116.21.4653.4653
Published: 2010
Journal Articles

Recombinant Human Coagulation Factor IX Expressed in HEK293 Cells: Influence of Serin Phosphorylation and Tyrosine Sulfation on Pharmacokinetic Properties in FIX-Knock-out Mice

Ernst Boehm, PhD, Michael Dockal, PhD, Meinhard Hasslacher, PhD, Artur Mitterer, PhD, Eva M Muchitsch, PhD, Manfred Reiter, PhD, Friedrich Scheiflinger, PhD
Journal: Blood
Blood (2008) 112 (11): 4098.
https://doi.org/10.1182/blood.V112.11.4098.4098
Published: 2008
Journal Articles

Biochemical and Functional Characterization of a Serum-Free rVWF Drug Candidate.

Peter L. Turecek, PhD, H. Peter Matthiessen, PhD, Artur Mitterer, PhD, Herbert Gritsch, PhD, Katalin Váradi, PhD, Barbara Plaimauer, PhD, Martin Purtscher, PhD, Wilfried Woehrer, PhD, Eva-Maria Muchitsch, DVM, Hans Peter Schwarz, MD
Journal: Blood
Blood (2006) 108 (11): 1017.
https://doi.org/10.1182/blood.V108.11.1017.1017
Published: 2006
Journal Articles

In Vivo Characterization of Recombinant von Willebrand Factor in Dogs With von Willebrand Disease

Peter L. Turecek, Herbert Gritsch, Ludwig Pichler, Wilfried Auer, Bernhard Fischer, Artur Mitterer, Wolfgang Mundt, Uwe Schlokat, Friedrich Dorner, Herm Jan M. Brinkman, Jan A. van Mourik, Hans Peter Schwarz
Journal: Blood
Blood (1997) 90 (9): 3555–3567.
https://doi.org/10.1182/blood.V90.9.3555
Published: 1997